Cutis
Drug
GRT US Holding, Inc.
Total Payments
$13,262
Transactions
3
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $13,262 | 3 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $10,262 | 2 | 77.4% |
| Consulting Fee | $3,000 | 1 | 22.6% |
Top Doctors Receiving Payments for Cutis
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Surgical Critical Care | Boston, MA | $13,262 | 3 |
Ad
Manufacturing Companies
- GRT US Holding, Inc. $13,262
Product Information
- Type Drug
- Total Payments $13,262
- Total Doctors 1
- Transactions 3
About Cutis
Cutis is a drug associated with $13,262 in payments to 1 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is GRT US Holding, Inc..
Payment data is available from 2018 to 2018. In 2018, $13,262 was paid across 3 transactions to 1 doctors.
The most common payment nature for Cutis is "Travel and Lodging" ($10,262, 77.4% of total).